Kowalski A, Mueller T C, Nowak P. "一种的合成方法" [P]. European Patent, EP 3417879 A1, 2025-06-17.
发明人何建平,王建平,朱建伟. "Method for the Synthesis of Ethyl 4-[5-[[(3R)-1-tert-Butoxycarbonylpyrrolidin-3-yl]carbamoyl]-2-pyridyl]piperazine-1-carboxylate" [P]. 中国发明专利, 专利号 CN 113115050 A, 授权公告日 2021-05-02.
参考文献 Literature
Brown R C, Davis S M. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Agric. Food Chem., 2010, 2327, 4198-4212.
Lee J H, Choi Y S. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Chromatographia, 2014, 672, (5), 8513-8534.
Kim S H, Park J Y. "Identification and Structural Characterization of a Novel Degradation Product of Ethyl 4-[5-[[(3R)-1-tert-Butoxycarbonylpyrrolidin-3-yl]carbamoyl]-2-pyridyl]piperazine-1-carboxylate Using HRMS and NMR". J. Nat. Prod., 2018, 1776, 2777-2804.
Jensen P, Larsen A M, Olsen K. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Chromatogr. A, 2011, 1342, 8815-8835.